By using our site you accept the terms of our cookie policy


MIP Diagnostics Ltd

March 8, 2019

MIP Diagnostics Ltd

MIP Commercialisation Experts of the Year 2019 - UK

MIP Diagnostics Ltd was founded in 2015 to commercialise various forms of Molecularly Imprinted Polymers (MIPs), sometimes called "plastic antibodies". 

In particular, we focus on NanoMIPs - nano-structured polymer particles which typically contain a single binding site for their target molecule, and rationally designed polymers (RDPs). NanoMIPs have broad application as affinity reagents in sensing, imaging, purification, analysis and diagnostics. Indeed, they have the potential to displace antibodies in many applications. 

nanoMIPs are prepared via a proprietary imprinting process involving self-assembly of binding monomers around a target molecule – these monomers are then polymerised to generate a ‘chemical receptor’ with high affinity and specificity to the target.

Unlike antibodies NanoMIP production does not require use of animals and they have a long shelf life at room temperature.  

Contact Us

+44 (0) 203 725 6847